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Abstract
T-cell characteristics are dynamic and influenced by multiple factors. To test whether cells and the environment in the
central nervous system (CNS) can influence T-cells, we tested if culturing mouse CD4+ T-cells on mouse primary astrocytes,
compared with standard feeder cells, modified T-cell polarization to Th1 and Treg subtypes. Astrocytes supported the
production of Th1 cells and Tregs, which was diminished by inflammatory activation of astrocytes, and glutamate
accumulation that may result from impaired glutamate uptake by astrocytes strongly promoted Th1 production. These
results demonstrate that astrocytes and the environment in the CNS have the capacity to regulate T-cell characteristics.
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Introduction
Recently there has been a rapidly increasing recognition that
extensive interactions occur between the immune and nervous
systems [1,2]. This progress is revising previous dogmas about the
insular actions of these two systems, revealing instead that there
are often bidirectional immune-neural interactions. An important
one of these is the actions of T cells in the central nervous system
(CNS), which is now known to include both beneficial and
detrimental influences of T cells on CNS functions [3,4,5].
Beneficial CNS actions of T cells have been particularly well-
established for their roles in contributing to cognition [6,7,8,9,10]
and hippocampal neurogenesis in adult mammals [5,7,11]. Also
well-established are the detrimental actions of T cells in certain
CNS diseases, such as being major drivers of the onset and
progression of multiple sclerosis [12,13].
Multiple sclerosis is the most common inflammatory demyelin-
ating disease of the CNS and is widely considered an autoimmune
disease caused by autoreactive T cells [13,14]. Several of the
clinical, immunological, and neuropathological features of MS are
modeled in experimental autoimmune encephalomyelitis (EAE),
which is induced in susceptible mice by eliciting an immune
response to injected myelin antigens [15,16]. The two major
populations of effector T helper (Th) cells present in the CNS of
mice that are thought to contribute to EAE are interferon-c
(IFNc)-producing Th1 cells and interleukin-17A (IL-17A)-produc-
ing Th17 cells. The differentiation of naive CD4+ T cells into
subtypes results from the activation of their T cell receptor (TCR)
and co-stimulatory molecules in the presence of specific cytokines
produced by the innate immune system [17]. IFNc and IL-12
induce the differentiation of CD4+ T cells to Th1 cells [18,19],
whereas TGFb induces anti-inflammatory regulatory T (Treg) cell
production [20]. Recent discoveries that T cell subtype charac-
teristics can be dynamic [21,22] have added a layer of complexity
and indicates that environmental influences are capable of
modulating the subtype characteristics of T cells.
Although it is evident that T cells in the CNS have a variety of
actions, little is known about how the environment within the CNS
affects T cells. Astrocytes are situated close to blood vessels, thus
being an early cellular contact of infiltrating CD4+ T cells [23,24].
Using in vitro co-cultures of cells, previous studies have reported
that microglia and astrocytes, as well as neurons, can influence the
priming or activation of T cells [25,26,27,28,29,30]. However it is
not clear if astrocytes can affect T cell differentiation character-
istics, even though astrocytes are capable of producing key
regulatory cytokines [23]. In the present study, the co-culture
approach was applied to test if mouse primary astrocytes are
capable of influencing the differentiation of co-cultured CD4+ T
cells to Th1 cells or Tregs.
Materials and Methods
Ethics Statement
All mice were housed and treated in accordance with National
Institutes of Health guidelines and procedures with mice were
approved by the University of Miami Institutional Animal Care
and Use Committee (11-233, 11-238).
Mice
C57BL/6 (6–8 weeks) mice were purchased from the Jackson
Laboratories. Mice were housed in a light and temperature
controlled room and treated in accordance with NIH and
University of Miami Institutional Animal Care and Use Commit-
tee regulations.
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Astrocyte culture
Primary glia were prepared from cerebral cortices of 1 day old
C57Bl/6 mice as described [31,32], and cultured in DMEM//F12
medium supplemented with 10% fetal bovine serum (FBS), 0.3%
glucose, 2 mM L-glutamine, 10 U/mL penicillin and 10 mg/mL
streptomycin. For separation of astrocytes and microglia, after 10
days of culture the cells were shaken (30 h; 250 rpm) and released
microglia were discarded, to obtain .99% pure astrocytes as
determined by immunostaining with the astrocyte marker glial
fibrillary acidic protein (GFAP) (Millipore, Bedford, MA), ,1%
were microglia. Protein-free E. coli (K235) LPS was prepared as
described [33]. Cells were left untreated or stimulated with
100 ng/mL LPS for 6 h (to induce cytokine production) in
medium supplemented with 10% FBS.
CD4+ T cell isolation and activation
Spleens and lymph nodes were collected and single-cell
suspensions were prepared by mechanical disruption in RPMI
1640 medium supplemented with 10% FBS, 100 IU/mL of
penicillin, 100 mg/mL of streptomycin, 16 nonessential amino
acids, 1 mM sodium pyruvate, 2.5 mM b-mercaptoethanol and
2 mM L-glutamine (R-10). CD4+ T cells were isolated by
magnetic sorting with DynaLbeads mouse CD4+ beads according
to the manufacturer’s instructions (Invitrogen). Methods for
differentiation of T cells were adapted from previously described
procedures [34]. Conventional irradiated (3,000 rads) spleen and
draining lymph node feeder cells were used as APCs, except where
indicated otherwise, and were cultured with purified CD4+ T cells
at a ratio of 5:1. Alternatively, the same number of CD4+ T cells
was cultivated on a confluent monolayer of astrocytes. CD4+ T
cells were activated with 2.5 mg/mL anti-CD3 (clone 145-11), Th1
cells were differentiated by the addition of recombinant IL-12
(10 ng/mL; R&D Systems) and anti-IL-4 (10 mg/mL; clone
11B11), and Tregs were prepared by incubation with TGFb
(5 ng/mL), anti-IL-4 (10 mg/mL; clone 11B11) and anti-IFN-c
(10 mg/mL; clone XMG1.2).
CD4+ T cells were cultivated with astrocytes in R10 medium.
Where indicated, cells were treated with 10 ng/mL brain-derived
nerve growth factor (BDNF), 100 ng/mL nerve growth factor
(NGF), 10 ng/mL glial derived nerve factor (GDNF), 100 mM
glutamate, or 100 mM MK-801 (Sigma).
Intracellular cytokine staining
Astrocytes and CD4+ T cells were collected by mechanical
pipetting and were stimulated for 4 h with PMA (50 ng/mL;
Alexis) and ionomycin (750 ng/mL; Sigma) in the presence of
Brefeldin A (BFA) at the recommended concentrations (BD
Pharmingen) in a 96 well plate. Standard intracellular cytokine
staining was carried out as described [34]. Cells were first stained
extracellularly with APC–conjugated anti-CD4 (eBioscience) and
fixed and permeabilized with Cytofix/Cytoperm solution (BD
Pharmingen) and then were stained intracellularly with eFluo450-
conjugated anti-IFN-c, phycoerythrin-conjugated anti-IL-17A,
(eBioscience). Samples were acquired on a LSRII (BD) and data
were analyzed with FlowJo software (Tree Star, Inc.).
Carboxyfluorescein succinimidyl ester (CFSE) labeling
CD4+ T cells were suspended at a density of 107 cells per mL in
PBS. CFSE (Molecular Probe) diluted in PBS was added to an
equal volume of prewarmed cell suspension at a final concentra-
tion of 5 mM and the suspension was mixed rapidly. Cells were
incubated at room temperature for 7 min and the reaction was
stopped with FBS. Cells were centrifuged and resuspended in
culture medium.
Microscopic evaluation of the number of CD4+ T cells per
astrocyte
To determine if the astrocytes and the CD4+ T cells come in
close contact, the proximity of the nuclei of CD4+ T cells to the
nuclei of astrocytes was evaluated by microscopy. The method was
modified from [35]. Cells were co-cultured, stained with Hoechst
and fixed with 3.2% PFA. A ThermoFisher Cellomics ArrayScan
VTI automated fluorescent microscope was used to image the
wells with a 106 objective at 102461024 resolution with 9 fields
per well of a 24-well plate containing co-cultured astrocytes and
CD4+ T cells. Hoechst was used to segment and identify the nuclei
of all cells, and the size and intensity of each individual nucleus
was identified using Cellomic’s ‘‘TARGET ACTIVATION’’
algorithm. This technique is comparable to looking at forward
scatter and Hoechst MFI in flow-cytometry, only the location
information about astrocytes and T cells is preserved. Spotfire
DecisionSite software (TIBCO) was used to analyze the data to
distinguish between the two populations of cells, in the same way
that populations of cells are ‘gated’ in flow cytometry (based on
controls with only one of the cell-types present).
Statistical analysis
Statistical significance was analyzed with a Mann-Whitney test
or one way ANOVA with Bonferroni post-test using Prism
software. A p value of less than 0.05 was considered significant.
Results
Astrocytes are sufficient to induce differentiation of CD4+
T cells to Th1 cells
We tested if astrocytes influence the polarization of CD4+ T
cells to Th1 or Treg cells by comparing T cell populations after
cultivating CD4+ T cells for 4 days on a monolayer of mouse
primary astrocytes or on conventional irradiated spleen and
draining lymph node feeder cells. Culturing CD4+ T cells with
astrocytes without supplements of additional cytokines was
sufficient to induce polarization of 12.7% of cells to IFNc-
producing CD4+ T cells, a marker of Th1 cells (Figure 1A).
Addition of anti-IL-4 antibody (Figure 1B) increased the IFNc-
producing CD4+ T cell population by 3.4-fold to 4262% of cells
(quantitation in Figure 1C), whereas culturing CD4+ T cells on
conventional feeder cells with anti-IL-4 only polarized 13.264%
of CD4+ T cells to IFNc-producing cells (Figure 1C). IL-12 is
classically used to polarize CD4+ T cells to IFNc-producing cells.
Upon addition of IL-12 (Figure 1C, D), astrocytes promoted the
differentiation of 9462% CD4+ T cells towards Th1 cells ,
whereas IL-12 addition to feeder cell cultures resulted in the
production of only 3367% of IFNc-producing CD4+ T cells.
These results demonstrate that astrocytes can be potent inducers of
Th1 cell production, and that the effects of astrocytes are additive
to the effect of IL-12 on promoting Th1 cell differentiation.
Culturing CD4+ T cells on astrocytes also supported polariza-
tion to Tregs. Culturing CD4+ T cells on astrocytes with added
TGFb and anti-IL-4 strongly induced Treg cell (3962%)
production to an extent equivalent to cells cultured on conven-
tional feeder cells (4269%) (Figure 1E, F).
Inflammation usually coincides with increased infiltration of T
cells in the CNS in conditions such as multiple sclerosis and EAE.
Therefore, we tested if activated astrocytes that produce increased
amounts of cytokines influence Th differentiation differently from
resting astrocytes. Astrocytes were pre-activated by overnight
Astrocytes Modulate Th1 Cells
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stimulation with lipopolysaccharide (LPS), followed by washing the
cells before co-culturing with CD4+ T cells. Surprisingly, activated
astrocytes inhibited Th1 differentiation in the absence of IL-12,
but were without effect in the presence of IL-12 (Figure 2A).
Activated astrocytes also inhibited Treg differentiation (Figure 2B).
These results indicate that resting and activated astrocytes
differently modulate T cells. Without activation astrocytes
promote the production of Th1 and Treg cells, whereas this is
impaired upon culturing CD4+ T cells on pre-activated astrocytes.
Cross-talk between Th1 cells and astrocytes is necessary
to promote full Th1 differentiation
To test the hypothesis that a factor secreted by astrocytes
promoted Th1 differentiation, CD4+ T cells were cultivated with
conditioned medium from cultured astrocytes. There was no effect
of the conditioned medium on Th1 cell differentiation (Figure 3A),
since it did not induce Th1 differentiation (Figure 1). This suggests
that it is not a factor secreted by astrocytes in the absence of CD4+
T cells that promotes Th1 cell production. Instead, we hypoth-
Figure 1. Astrocytes alone are sufficient to induce Th1 cell production. (A) CD4+ T cells were cultivated for 4 days on no feeder cells or on a
monolayer of astrocytes. (B) CD4+ T cells were cultivated for 4 days on no feeder cells, on a monolayer of astrocytes, or on irradiated splenocyte
feeder cells with 10 mg/mL anti-IL-4. (C) CD4+ T cells were cultivated for 4 days on no feeder cells, on a monolayer of astrocytes, or on irradiated
splenocyte feeder cells with 10 mg/mL anti-IL-4 and 10 ng/mL IL-12. (A–D) IFNc-producing, Foxp3 expressing and IL-17A-producing CD4+ T cells were
analyzed by flow cytometry after restimulation with ionomycin/PMA/BFA for 4 h. Flow cytometry analyses were quantified and expressed as mean6
s.e.m. (for the data in D: n = 4–8, Mann-Whitney test, *p,0.05 compared with cells incubated without anti-IL-12). (E, F) CD4+ T cells were cultivated for
4 days on a monolayer of astrocytes or on irradiated splenocyte feeder cells with 10 mg/mL anti-IL-4, with or without 5 ng/mL TGFb. Foxp3-
expressing cells were analyzed by flow cytometry. Flow cytometry analyses were quantified and expressed as mean 6 s.e.m. (n = 4, Mann-Whitney
test, *p,0.05 compared with cells incubated without TGFb).
doi:10.1371/journal.pone.0086257.g001
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esized that CD4+ T cells stimulate astrocytes to release a factor
that promotes Th1 differentiation. To test this, serial dilutions of
CD4+ T cells were cultivated with astrocytes and the proportion of
the generation of IFNc-producing cells was measured. Increasing
dilutions of CD4+ T cells cultivated with astrocytes led to
decreased percentages of Th1 cell production (Figure 3B), while
there was no difference for Treg differentiation (Figure 3C). This
suggests that there is a feedback loop by which the CD4+ T cells
signal to astrocytes to induce production of factors that promote
Th1 cell differentiation.
Are mitogenic factors involved in Th1 cell differentiation
induced in the presence of astrocytes?
CFSE staining of CD4+ T cells cultured on astrocytes showed
that cells incubated in Th1 polarizing conditions had a higher rate
of cell division than undifferentiated CD4+ T cells or than cells
incubated on irradiated lymph node cells and splenocytes in Th1
polarizing conditions (Figure 4A), suggesting that astrocytes may
produce a mitogenic factor that promotes CD4+ T cell prolifer-
ation and differentiation. We tested if the addition of several
mitogenic factors known to be secreted by astrocytes [36,37]
modulate Th1 differentiation of CD4+ cells cultured on spleno-
cytes, including nerve growth factor (NGF), glial derived nerve
factor (GDNF) and brain-derived nerve growth factor (BDNF).
However, there was no increase in the Th1 cell differentiation in
the presence of these factors (Figure 4B).
Glutamate modulates Th1 cell production
An important function of astrocytes is the buffering of
glutamate, which is critical for controlling extracellular glutamate
levels and for protecting neurons from excitotoxicity [36,37]. Since
this function can be impaired in CNS diseases, resulting in
increased extracellular glutamate levels, we tested if glutamate
impacts Th1 cell differentiation. Addition of glutamate promoted
Th1 differentiation of CD4+ T cells cultured on splenocytes in the
presence of anti-IL-4 and IL-12 (Figure 5). Conversely, treatment
with the selective NMDA receptor antagonist MK801 reduced
Th1 cell differentiation (Figure 5A). Moreover, addition of
glutamate on CD4+ T cells was sufficient to increase TBet
expression, a marker of Th1 differentiation (Figure 5B). This
suggests that in addition to producing cytokines critical for Th1
cell differentiation, the regulation of glutamate levels by astrocytes
may also be an important modulator of the production of Th1
cells, similar to a previous report that glutamate released from DCs
can regulate the secretion of Th1 cytokines [38].
Th1 cells are dependent on CD4 for their differentiation
on astrocytes
Because the extent of direct interaction between CD4+ T cells
and feeder cells may have a regulatory role in the differentiation of
CD4+ T cells towards specific lineages, we examined if the number
of CD4+ T cells associated with astrocytes was different among
subpopulations of Th cells by measuring the number of CD4+ T
cells associated with astrocytes using high content analysis.
Astrocytes (Figure 6A, D) and T cells (Figure 6B,D) were
distinguished based on nuclear size and intensity, based on
thresholds established from control wells with a single cell type.
CD4+ T cells were observed to be in close proximity to astrocytes
(Figure 6B), and there were similar numbers of astrocyte-
associated anti-IL-4 treated CD4+ T cells, Th1, and Tregs
(Figure 6C). We next tested if blocking the CD4-mediated cell-
cell interaction influences the differentiation of Th1 cells on
astrocytes by incubation with a neutralizing antibody for CD4.
Blocking CD4 was sufficient to block the differentiation towards
Figure 2. Preactivation of astrocytes reduces Th1 differentiation. CD4+ T cells were cultivated for 4 days on a monolayer of astrocytes that
were pre-activated with LPS for 18 h, with or without 10 mg/mL anti-IL-4 and 10 ng/mL IL-12 where indicated. IFNc-producing (A) and Foxp3
expressing (B) CD4+ T cells were analyzed by flow cytometry after restimulation with ionomycin/PMA/BFA for 4 h. Flow cytometry analyses were
quantified and expressed as mean 6 s.e.m. (for the data in A: n = 3, one-way ANOVA test, *p,0.05; for the data in B: n = 2–4).
doi:10.1371/journal.pone.0086257.g002
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Th1 cultured on astrocytes (Figure 6E), without affecting the
percent of CD4+ T cells associated per astrocyte (Figure 6F),
suggesting that the CD4 signaling is important for Th1 differen-
tiation of CD4+ T cells cultured on astrocytes.
Discussion
In contrast to previous dogmas that T cell subtypes and
characteristics are stable, it is rapidly becoming clear that T cell
characteristics are dynamic and subject to change in response to
the environment and other factors [21,22]. This raises the
likelihood that T cells in the CNS are responsive to alterations
in the environment created by resident cells. To begin to test if
astrocytes can modify T cell characteristics, we used the
straightforward paradigm of testing in vitro if astrocytes are
capable of influencing the development of CD4+ T cells to
different subtypes. The results show that resting astrocytes
predominantly promote the development of Th1 cells, but this is
diminished after activation of astrocytes.
During MS and EAE, peripheral Th1 cells accumulate in the
CNS and contribute to demyelination, whereas Tregs are
protective [13,14]. Here we provide evidence that CNS resident
astrocytes may also play a role in contributing to the regulation of
Th1 and Treg cells. Astrocytes promoted Th1 differentiation in
the absence or presence of exogenous IL-12, but this was impaired
when CD4+ T cells were cultured on astrocytes pre-activated with
LPS. This raises the possibility that depending on the environment
in the CNS, astrocytes can contribute to the orientation of T cell
characteristics towards subsets of Th cells. Although T cells in the
CNS are thought to predominantly express subtype characteristics
Figure 3. Cross-talk between Th1 cells and astrocytes is necessary to promote maximal Th1 differentiation. (A) CD4+ T cells were
polarized toward Th1 cells for 4 days in conditioned medium from unstimulated or LPS-stimulated astrocytes supplemented with 10 ng/mL IL-12
(Th1) or 5 ng/mL TGFb (Treg). Cells were washed and stimulated for 4 h with PMA/ionomycin/BFA and IFNc-producing CD4+ T and Foxp3 expressing
CD4+ T cells were analyzed by flow cytometry. Flow cytometry analyses were quantified and expressed as mean 6 s.e.m. (n = 2). (B–C) Different
quantities of CD4+ T cells were cultivated on an astrocyte monolayer and polarized toward (B) Th1, or (C) Treg cells for 4 days in medium
supplemented with 10 ng/mL IL-12 (Th1), or 5 ng/mL TGFb (Treg). Cells were washed, stimulated for 4 h with PMA/ionomycin/BFA, and IFNc-
producing and Foxp3-expressing CD4+ T cells were analyzed by flow cytometry. Flow cytometry analyses were quantified and expressed as mean 6
s.e.m. (n = 3, , one-way ANOVA test, *p,0.05 compared to 56105 cells).
doi:10.1371/journal.pone.0086257.g003
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prior to infiltration, these results suggest that astrocytes may
contribute to shifts in the subtype characteristics, or influence the
development of any immature infiltrated CD4+ T cells, although
each of these will require in vivo investigations.
In order to determine which specific astrocytic factors
contribute to their modulation of Th1 cell differentiation, we
analyzed candidates known to be involved in the functions of
astrocytes. Among their actions, astrocytes are involved in
neurotransmitter regulation, have mitogenic functions, and are
modulators of inflammation [36,37]. Because the proliferation of
Th1 cells was increased in the presence of astrocytes compared
with cells cultured on irradiated splenocytes, we tested if mitogenic
Figure 4. Th1 differentiation is not dependent on GDNF, BDNF or NGF. (A) CD4+ T cells were polarized toward Th1 cells for 3 days cultured
on astrocytes or with irradiated feeder cells in medium supplemented with 10 ng/mL IL-12 (Th1). Cells were washed and stimulated for 4 hr with
PMA/ionomycin and CD4+ T cells were analyzed for CFSE staining by flow cytometry gated on IFNc+CD4+ T cells. Data are representative of 2
independent experiments. The rate of cell division was higher in cells incubated in Th1-polarizing conditions than undifferentiated cells. (B) CD4+ T
cells cultivated on astrocytes or irradiated splenocytes were stimulated with 10 ng/mL GDNF, 10 ng/mL BDNF, 100 ng/mL NGF, or a combination as
indicated, in the presence or not of Th1 polarizing conditions for 4 days. Cells were washed and stimulated with PMA/ionomycin/BFA for 4 h and
IFNc-producing cells were analyzed by flow cytometry. Plots are representative of 2 independent experiments.
doi:10.1371/journal.pone.0086257.g004
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factors secreted by astrocytes may be involved. However,
incubation with NGF, BNDF or GDNF did not modulate Th1
cell differentiation, indicating that astrocytes can regulate Th1 cells
by other factors or at the MHC level. The latter is consistent with
the previous proposal that the strength of the TCR-MHC
interaction is critical for Th1 differentiation and proliferation.
Glutamate appears to be an important regulator of T cell
function. T cells have been shown to express many of the subtypes
of glutamate receptors [39,40,41,42]. Exposure to glutamate has
Figure 5. Th1 cell differentiation is promoted by glutamate. (A) CD4+ T cells were cultivated on irradiated splenocytes in the presence of
10 mg/mL anti-IL-4 alone or with 10 ng/mL IL-12 for 4 days, with or without 100 mM MK801 or 100 mM glutamate, each of which was reloaded after 2
days of polarization. Cells were washed and restimulated with PMA/ionomycin/BFA for 4 h and analyzed by flow cytometry. Flow cytometry analyses
were quantified and expressed as mean 6 s.e.m. (n = 3, one-way ANOVA test, *p,0.05). (B) CD4+ T cells were cultivated on irradiated splenocytes in
the presence 10 mg/mL anti-IL-4 for 4 days with or without 100 mM glutamate, and cells were washed and restimulated with PMA/ionomycin/BFA for
4 h and analyzed by flow cytometry. The histogram represents TBet expressing cells.
doi:10.1371/journal.pone.0086257.g005
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Figure 6. Th1 cell differentiation is promoted by CD4+ T cell activation. CD4+ T cells were cultivated on astrocytes in the presence of 10 mg/
mL anti-IL-4 alone (anti-IL-4), with 10 mg/mL anti-IL-4 and 10 ng/mL IL-12 (Th1), or with 10 mg/mL anti-IL-4 and 2.5 ng/mL TGFb (Treg) for 4 days. Cells
were stained with Hoechst and fixed and analyzed using an ArrayScan VTI automated fluorescent microscope. (A) astrocytes alone with nuclei traced
(a 20-fold magnification is shown in the small box), (B) astrocytes co-cultured with CD4+ T cells with nuclei traced (a 20-fold magnification is shown in
the small box), (C) quantitation of percent of CD4+ T cells associated per astrocyte (mean 6 s.e.m.; n = 3), (D) scatter plot showing the cells identified
as astrocytes (red) and CD4+ T cells (blue). (E) CD4+ T cells were cultivated on astrocytes in the presence of 10 mg/mL anti-IL-4 and 10 ng/mL IL-12 for
4 days, with or without 10 mg/mL anti-CD4 (GK1.5). Cells were washed, and restimulated with PMA/ionomycin/BFA for 4 h and analyzed by flow
cytometry. The histogram represents IFNc-expressing CD4+ T cells (n = 2, unpaired t-test *p,0.05). (F) CD4+ T cells were cultivated on astrocytes in
the presence of 10 mg/mL anti-IL-4 and with 10 ng/mL IL-12 for 4 days, with or without 10 mg/mL anti-CD4 (GK1.5). Cells were stained with Hoechst
and fixed and analyzed with an ArrayScan VTI automated fluorescent microscope. Bars represent mean 6 s.e.m. (n = 3).
doi:10.1371/journal.pone.0086257.g006
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been reported to modulate several functions and the proliferation
of T cells by activating glutamate receptors expressed by T cells
[38,43,44,45,46,47,48,49]. Furthermore, the NMDA receptor
antagonist memantine was reported to promote the development
of Tregs [50]. A major function of astrocytes is to take up the
neurotransmitter glutamate to prevent its accumulation in the
synapse where it can reach levels sufficient to cause excitotoxicity
in some neurological diseases. We found that glutamate has the
capacity to regulate Th1 cells, as addition of exogenous glutamate
promoted the production of Th1 cells. Thus, although it has been
known for several years that astrocytes can interact with T cells via
MHC-TCR interactions, these findings indicate that astrocytes
also may affect the characteristics of T cells in the CNS, such as
Th1 cell production, but whether this is critical in the development
of EAE or other diseases remains to be determined. Furthermore,
CD4 activation was found to be important for the differentiation
of CD4+ T cells toward Th1 cells cultured on astrocytes,
confirming that the TCR pathway plays an important role, since
CD4 is a co-receptor of the TCR.
Although it is evident that T cells in the CNS have a variety of
actions, evidence that the environment within the CNS affects
resident T cells is only recently being identified. Thus, significant
advances have recently been made concerning mechanisms
regulating the infiltration of T cells and their actions in the
CNS, but still to be defined is the dynamicity of their
characteristics and the influence of the environment in the CNS
on their characteristics and actions. The recent rapid growth of
identified actions of T cells in healthy and diseased CNS and of the
dynamic characteristics of T cells indicates that the capacity for
unanticipated CNS-immune interactions should not be underes-
timated, such as the capacity of CNS cells to influence T cell
characteristics as reported here.
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